TAF7 and breast carcinoma: In addition, some studies noted that TAF7 was frequently overexpressed in various cancers through bioinformatics analysis and experimental verification including breast cancer 24, glioblastoma 25, lung adenocarcinoma 37 and colorectal cancer 38.